Developer docs
API playgroundTry for free, no card

Search company profiles

Colompack

Full company profile

uuid0021tnl

Namestring
Colompack
Legal namestring
Colompack S.A.
Websiteurl
colompack.co
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Colompack S.A. is a privately held Colombian pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Bogotá, operating since 1999. The company provides an integrated portfolio of five services for human and veterinary pharmaceutical products: Maquila (contract manufacturing of solid, semi-solid, and liquid dosage forms including powders, tablets, hard gelatin capsules, syrups, suspensions, emulsions, creams, gels, and ointments); R&D (preformulation, formulation, reformulation, pilot batches, industrial scale-up, and technology transfer); Stability Studies (ICH-compliant pre-stability, accelerated, natural, and ongoing programs for climatic zone IV-B); Laboratory Analysis and Quality Control under Good Laboratory Practices (raw material, packaging, in-process, and finished product testing using HPLC, UV-Vis, IR, and dissolution techniques); and 360-degree Raw Materials Supply with pharmacopeial analysis. The company holds Good Manufacturing Practices (BPM) certifications from INVIMA for human products and ICA for veterinary products, plus Good Laboratory Practices (BPL) certification from INVIMA.

Colompack's business model is B2B sales-led, selling integrated services directly to pharmaceutical laboratories through direct engagement, contact forms, phone, and email. Revenue is generated through one-time maquila contracts, per-test laboratory fees, project-based stability studies and R&D engagements, and transaction fees on raw materials supply. Pricing is quote-based and not publicly disclosed. The company's stated headcount range is 101-250 employees, operating from a single Bogotá facility at Carrera 46 #20B-34. The marketed customer base includes 11 named enterprise pharmaceutical clients such as MEGALABS, Lab Bagó, GRUINFACOL, SUIPHAR INTERNACIONAL, Farma de Colombia, GIMED, IMPOFAR, Laboratorios Best, NeVox, RGB-CC, and RGB-MP, all operating primarily in the Colombian market.

The company is privately held with no disclosed funding rounds, no subsidiaries, no M&A activity, and no patents or trademarks recorded. Marketing presence is limited to a corporate website and LinkedIn profile. Operating geography is restricted to Colombia within the LATAM region, with no international expansion claims in the source material.

Short descriptiontext

Colompack S.A. is a Bogotá-based, privately held Colombian pharmaceutical CDMO founded in 1999, offering integrated maquila, R&D, stability, lab analysis, and raw materials supply services to human and veterinary pharmaceutical laboratories under INVIMA and ICA certifications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBogotá, Colombia
HQ citystring
Bogotá
HQ countrystring
Colombia
HQ regionstring
Latin America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical contract manufacturing, pharmaceutical R&D services, stability studies, laboratory quality control, raw material supply
Industry2 codes
PRIMARYHLAGAHAL
GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
  • Scientific Research and Development Services5417
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Services-Medical Laboratories8071
Product category
Pharmaceutical Contract Manufacturing Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Contract Manufacturing (Maquila)
TypeOne Time License
Description

Pharmaceutical manufacturing services for solid, semi-solid, and liquid dosage forms for human and veterinary use. Includes primary and secondary packaging services.

colompack.co
2Laboratory Testing Services
TypeProfessional Services
Description

Physical-chemical analysis services including raw materials testing, packaging materials testing, finished product testing, and process/cleaning validations. Revenue generated per test or project.

colompack.co
3Stability Studies
TypeProfessional Services
Description

Pre-stability, accelerated and natural stability, and ongoing stability studies for pharmaceutical products following ICH guidelines in climatic zone IV-B.

colompack.co
4Research and Development Services
TypeProfessional Services
Description

New product development including preformulation, formulation, reformulation, pilot batches, industrial scale-up, and technology transfer services.

colompack.co
5Raw Materials Supply
TypeTransaction Fee
Description

Supply of pharmaceutical raw materials, active ingredients, excipients, standards, reagents, and special columns with pharmacopeial analysis.

colompack.co
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Colompack S.A. provides integrated pharmaceutical services for human and veterinary products, including contract manufacturing (maquila) of solid, semi-solid, and liquid dosage forms; research and development (preformulation, formulation, pilot batches, scale-up); GLP-certified laboratory analysis and quality control; ICH-compliant stability studies; and 360-degree raw materials supply. Services span from product idea through regulatory dossier preparation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Integrated services from R&D to regulatory affairs reduce client coordination burden
Product overview1 text field

Colompack S.A. is a pharmaceutical contract manufacturing and services company offering an integrated portfolio of five interconnected services for human and veterinary pharmaceutical products. The core offerings include Maquila (contract manufacturing with solid, semi-solid, and liquid pharmaceutical forms), Investigación y Desarrollo (R&D for new product development), Estudios de Estabilidad (stability studies), Análisis de Laboratorio y Control de Calidad (BPL-certified laboratory analysis and quality control), and Abastecimiento de Materias Primas e Insumos (raw material supply). These services are designed to provide clients with comprehensive support from product development through manufacturing, testing, and regulatory affairs.

Product and service5 records
1Maquila (Contract Manufacturing)
CategoryContract Manufacturing
Description

Comprehensive manufacturing services for pharmaceutical products for human and veterinary use, including solid forms (powders, coated and uncoated tablets, hard gelatin capsules), semi-solids (creams, gels, ointments, lotions), and liquids (syrups, solutions, suspensions, emulsions), with primary and secondary packaging capabilities for non-sterile medications.

2Investigación y Desarrollo (Research and Development)
CategoryResearch and Development
Description

Full-spectrum pharmaceutical R&D services for new product development including preformulation, formulation, reformulation, pilot batch production, industrial scale-up, and technology transfer for human and veterinary pharmaceutical products across multiple dosage forms.

3Estudios de Estabilidad (Stability Studies)
CategoryStability Testing Services
Description

Stability testing services including pre-stability, accelerated stability (40°C – 75% RH), natural stability (30°C – 75% RH for 0-36 months), ongoing stability, and analytical technique validation, compliant with ICH guidelines in climatic zone IV-B.

4Análisis de Laboratorio y Control de Calidad (Laboratory Analysis and Quality Control)
CategoryLaboratory Testing Services
Description

BPL-certified (Good Laboratory Practices) laboratory services for raw material analysis, packaging material testing, in-process and finished product analysis, process validation, and cleaning validation, utilizing techniques including HPLC, UV-visible spectroscopy, IR spectroscopy, and dissolution testing.

5Abastecimiento de Materias Primas e Insumos (Raw Material Supply)
CategoryRaw Material Supply
Description

360-degree raw material supply services including active pharmaceutical ingredients and excipients, standards and special reagents, special columns, and full supply chain management with pharmacopeial analysis, serving both internal maquila operations and external clients.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global CDMO providing pharma contract manufacturing and lab services across small molecules, biologics, and cell therapies. Comparable as a regulatory-certified, capital-intensive CDMO operating at meaningfully larger scale than Colompack.

2Eurofarma Laboratórios
TypeRegional player
Description

Brazilian pharmaceutical manufacturer with extensive LATAM CDMO and contract manufacturing footprint. Comparable as a multi-dosage-form CDMO serving Latin American pharmaceutical clients; an indirect regional peer rather than a direct Colombian competitor.

TypeBroad incumbent
Description

European pharmaceutical CDMO offering contract development and manufacturing for oral solids, semi-solids, and sterile dosage forms. Comparable as a broad-based CDMO with pharmaceutical manufacturing and lab testing services similar to Colompack's integrated offering.

4Procaps
TypeDirect peer
Description

Colombian pharmaceutical company with significant contract manufacturing capabilities in solid, semi-solid, and liquid dosage forms, serving both human and veterinary markets. Directly competes with Colompack in the domestic maquila segment for the same Colombian pharma clients.

5Recipharm
TypeBroad incumbent
Description

European pharmaceutical CDMO offering contract manufacturing of solid, semi-solid, and sterile dosage forms. Comparable as a large-scale contract manufacturer in the same dosage-form categories that Colompack services.

TypeBroad incumbent
Description

Global pharmaceutical CDMO offering contract development and manufacturing across oral, sterile, and biologic dosage forms. Comparable as a large-scale pharmaceutical contract manufacturer with regulatory expertise that occasionally services LATAM clients.

TypeBroad incumbent
Description

Swiss pharmaceutical CDMO offering API and finished dosage form manufacturing services globally. Comparable contract manufacturer profile with broad regulatory expertise relevant to Colompack's BPM-certified operations.

8Laboratorios Cryopharma
TypeEmerging player
Description

Smaller Colombian pharmaceutical manufacturer with contract manufacturing capabilities for human dosage forms. Comparable as a domestic Colombian CDMO peer competing for local pharma lab business in solid and semi-solid forms.

TypeEmerging player
Description

Glenmark Colombia is part of a multinational pharma manufacturer operating in the Colombian market with solid-dose capabilities; an emerging comparable as it competes for Colombian contract manufacturing work in adjacent dosage forms.

TypeDirect peer
Description

One of the largest Colombian pharmaceutical manufacturers with in-house R&D, manufacturing, and regulatory services. Competes with Colompack for contract manufacturing slots in solid and liquid dosage forms within the domestic Colombian market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Colompack

Pharmaceutical Contract Manufacturing Servicescolompack.co

Colompack S.A. is a Bogotá-based, privately held Colombian pharmaceutical CDMO founded in 1999, offering integrated maquila, R&D, stability, lab analysis, and raw materials supply services to human and veterinary pharmaceutical laboratories under INVIMA and ICA certifications.

What Colompack does

Colompack S.A. is a privately held Colombian pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Bogotá, operating since 1999. The company provides an integrated portfolio of five services for human and veterinary pharmaceutical products: Maquila (contract manufacturing of solid, semi-solid, and liquid dosage forms including powders, tablets, hard gelatin capsules, syrups, suspensions, emulsions, creams, gels, and ointments); R&D (preformulation, formulation, reformulation, pilot batches, industrial scale-up, and technology transfer); Stability Studies (ICH-compliant pre-stability, accelerated, natural, and ongoing programs for climatic zone IV-B); Laboratory Analysis and Quality Control under Good Laboratory Practices (raw material, packaging, in-process, and finished product testing using HPLC, UV-Vis, IR, and dissolution techniques); and 360-degree Raw Materials Supply with pharmacopeial analysis. The company holds Good Manufacturing Practices (BPM) certifications from INVIMA for human products and ICA for veterinary products, plus Good Laboratory Practices (BPL) certification from INVIMA.

Colompack's business model is B2B sales-led, selling integrated services directly to pharmaceutical laboratories through direct engagement, contact forms, phone, and email. Revenue is generated through one-time maquila contracts, per-test laboratory fees, project-based stability studies and R&D engagements, and transaction fees on raw materials supply. Pricing is quote-based and not publicly disclosed. The company's stated headcount range is 101-250 employees, operating from a single Bogotá facility at Carrera 46 #20B-34. The marketed customer base includes 11 named enterprise pharmaceutical clients such as MEGALABS, Lab Bagó, GRUINFACOL, SUIPHAR INTERNACIONAL, Farma de Colombia, GIMED, IMPOFAR, Laboratorios Best, NeVox, RGB-CC, and RGB-MP, all operating primarily in the Colombian market.

The company is privately held with no disclosed funding rounds, no subsidiaries, no M&A activity, and no patents or trademarks recorded. Marketing presence is limited to a corporate website and LinkedIn profile. Operating geography is restricted to Colombia within the LATAM region, with no international expansion claims in the source material.

Colompack firmographics

Firmographics
Name
Colompack
Legal name
Colompack S.A.
Website
https://colompack.co
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
101–250 employees
Short description
Colompack S.A. is a Bogotá-based, privately held Colombian pharmaceutical CDMO founded in 1999, offering integrated maquila, R&D, stability, lab analysis, and raw materials supply services to human and veterinary pharmaceutical laboratories under INVIMA and ICA certifications.
Ownership category
akta.pro rank

Colompack industry classification

Industry
Product category
Pharmaceutical Contract Manufacturing Services
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Scientific Research and Development Services (5417)
SIC
Pharmaceutical Preparations (2834), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGAHAL
GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)

Keywords

  • Pharmaceutical contract manufacturing
  • Pharmaceutical R&D services
  • Stability studies
  • Laboratory quality control
  • Raw material supply

Where Colompack is headquartered

Location

Headquarters

HQ city
Bogotá
HQ country
Colombia
HQ region
Latin America

Offices1 record

Markets served

Colompack business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Operations, Personnel, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. Contract Manufacturing (Maquila): Pharmaceutical manufacturing services for solid, semi-solid, and liquid dosage forms for human and veterinary use. Includes primary and secondary packaging services.
  2. Laboratory Testing Services: Physical-chemical analysis services including raw materials testing, packaging materials testing, finished product testing, and process/cleaning validations. Revenue generated per test or project.
  3. Stability Studies: Pre-stability, accelerated and natural stability, and ongoing stability studies for pharmaceutical products following ICH guidelines in climatic zone IV-B.
  4. Research and Development Services: New product development including preformulation, formulation, reformulation, pilot batches, industrial scale-up, and technology transfer services.
  5. Raw Materials Supply: Supply of pharmaceutical raw materials, active ingredients, excipients, standards, reagents, and special columns with pharmacopeial analysis.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Colompack product offering

Product offering

Core offering

Colompack S.A. provides integrated pharmaceutical services for human and veterinary products, including contract manufacturing (maquila) of solid, semi-solid, and liquid dosage forms; research and development (preformulation, formulation, pilot batches, scale-up); GLP-certified laboratory analysis and quality control; ICH-compliant stability studies; and 360-degree raw materials supply. Services span from product idea through regulatory dossier preparation.

Product overview

Colompack S.A. is a pharmaceutical contract manufacturing and services company offering an integrated portfolio of five interconnected services for human and veterinary pharmaceutical products. The core offerings include Maquila (contract manufacturing with solid, semi-solid, and liquid pharmaceutical forms), Investigación y Desarrollo (R&D for new product development), Estudios de Estabilidad (stability studies), Análisis de Laboratorio y Control de Calidad (BPL-certified laboratory analysis and quality control), and Abastecimiento de Materias Primas e Insumos (raw material supply). These services are designed to provide clients with comprehensive support from product development through manufacturing, testing, and regulatory affairs.

Differentiator

Problem solved

Functional benefit

Products and services

  • Maquila (Contract Manufacturing) Comprehensive manufacturing services for pharmaceutical products for human and veterinary use, including solid forms (powders, coated and uncoated tablets, hard gelatin capsules), semi-solids (creams, gels, ointments, lotions), and liquids (syrups, solutions, suspensions, emulsions), with primary and secondary packaging capabilities for non-sterile medications.
  • Investigación y Desarrollo (Research and Development) Full-spectrum pharmaceutical R&D services for new product development including preformulation, formulation, reformulation, pilot batch production, industrial scale-up, and technology transfer for human and veterinary pharmaceutical products across multiple dosage forms.
  • Estudios de Estabilidad (Stability Studies) Stability testing services including pre-stability, accelerated stability (40°C – 75% RH), natural stability (30°C – 75% RH for 0-36 months), ongoing stability, and analytical technique validation, compliant with ICH guidelines in climatic zone IV-B.
  • Análisis de Laboratorio y Control de Calidad (Laboratory Analysis and Quality Control) BPL-certified (Good Laboratory Practices) laboratory services for raw material analysis, packaging material testing, in-process and finished product analysis, process validation, and cleaning validation, utilizing techniques including HPLC, UV-visible spectroscopy, IR spectroscopy, and dissolution testing.
  • Abastecimiento de Materias Primas e Insumos (Raw Material Supply) 360-degree raw material supply services including active pharmaceutical ingredients and excipients, standards and special reagents, special columns, and full supply chain management with pharmacopeial analysis, serving both internal maquila operations and external clients.

Quantifiable outcome

  • Integrated services from R&D to regulatory affairs reduce client coordination burden

Companies that use Colompack

Customer profile

Named customers11 records

Segments1 record

Ideal customer profiles1 record

Colompack technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Colompack partnerships and signals

Strategic signal

Scale indicators2 records

Expansion highlights3 records

Colompack competitors and assessment

Company assessment

Broad incumbents

  • Lonza Group: Global CDMO providing pharma contract manufacturing and lab services across small molecules, biologics, and cell therapies. Comparable as a regulatory-certified, capital-intensive CDMO operating at meaningfully larger scale than Colompack.
  • Aenova Group: European pharmaceutical CDMO offering contract development and manufacturing for oral solids, semi-solids, and sterile dosage forms. Comparable as a broad-based CDMO with pharmaceutical manufacturing and lab testing services similar to Colompack's integrated offering.
  • Recipharm: European pharmaceutical CDMO offering contract manufacturing of solid, semi-solid, and sterile dosage forms. Comparable as a large-scale contract manufacturer in the same dosage-form categories that Colompack services.
  • Catalent: Global pharmaceutical CDMO offering contract development and manufacturing across oral, sterile, and biologic dosage forms. Comparable as a large-scale pharmaceutical contract manufacturer with regulatory expertise that occasionally services LATAM clients.
  • Siegfried Holding: Swiss pharmaceutical CDMO offering API and finished dosage form manufacturing services globally. Comparable contract manufacturer profile with broad regulatory expertise relevant to Colompack's BPM-certified operations.

Regional players

  • Eurofarma Laboratórios: Brazilian pharmaceutical manufacturer with extensive LATAM CDMO and contract manufacturing footprint. Comparable as a multi-dosage-form CDMO serving Latin American pharmaceutical clients; an indirect regional peer rather than a direct Colombian competitor.

Direct peers

  • Procaps: Colombian pharmaceutical company with significant contract manufacturing capabilities in solid, semi-solid, and liquid dosage forms, serving both human and veterinary markets. Directly competes with Colompack in the domestic maquila segment for the same Colombian pharma clients.
  • Tecnoquímica: One of the largest Colombian pharmaceutical manufacturers with in-house R&D, manufacturing, and regulatory services. Competes with Colompack for contract manufacturing slots in solid and liquid dosage forms within the domestic Colombian market.

Emerging players

  • Laboratorios Cryopharma: Smaller Colombian pharmaceutical manufacturer with contract manufacturing capabilities for human dosage forms. Comparable as a domestic Colombian CDMO peer competing for local pharma lab business in solid and semi-solid forms.
  • Gienic Laboratorios: Glenmark Colombia is part of a multinational pharma manufacturer operating in the Colombian market with solid-dose capabilities; an emerging comparable as it competes for Colombian contract manufacturing work in adjacent dosage forms.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Colompack social profiles

Digital presence

Colompack compliance and trust

Trust signal

Compliance2 records

Colompack financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Colompack leadership team

Management profile

Number of profiles

Colompack funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Colompack M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Colompack

What does Colompack do?

Colompack S.A. provides integrated pharmaceutical services for human and veterinary products, including contract manufacturing (maquila) of solid, semi-solid, and liquid dosage forms; research and development (preformulation, formulation, pilot batches, scale-up); GLP-certified laboratory analysis and quality control; ICH-compliant stability studies; and 360-degree raw materials supply. Services span from product idea through regulatory dossier preparation.

Is Colompack a public or private company?

Colompack is a private company. It is classified as unknown and is currently operating.

When was Colompack founded?

Colompack was founded in 1999. It employs 101 to 250 people.

Where is Colompack based?

Colompack is headquartered in Bogotá, Colombia, in the Latin America region.

How does Colompack make money?

Five revenue lines are on record. Contract Manufacturing (Maquila) is the primary driver. The others are laboratory Testing Services, stability Studies, research and Development Services and raw Materials Supply.

Who are Colompack's main competitors?

Broad incumbents on record are Lonza Group, Aenova Group, Recipharm, Catalent and Siegfried Holding. Eurofarma Laboratórios is listed as a regional player. Direct peers are Procaps and Tecnoquímica. Emerging players are Laboratorios Cryopharma and Gienic Laboratorios.

Does Colompack have an API?

No public API is recorded for Colompack.

What industry is Colompack in?

Colompack's product category is Pharmaceutical Contract Manufacturing Services. Its primary akta.pro industry code is HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ), with a secondary code of HLAGAAAC, Toxicology & Safety Assessment CROs (GLP). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales